Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 May 6;65(5):2500273.
doi: 10.1183/13993003.00273-2025. Print 2025 May.

Rethinking pulmonary arterial hypertension care: the role of dual therapy in patients with cardiovascular comorbidities

Affiliations
Editorial

Rethinking pulmonary arterial hypertension care: the role of dual therapy in patients with cardiovascular comorbidities

Clara Hjalmarsson et al. Eur Respir J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: C. Hjalmarsson is a consultant and advisor for Johnson & Johnson, AOP Health/OrphaCare and MSD, clinical trial site PI or SI for Johnson & Johnson, United Therapeutics, Boehringer Ingelheim, Acceleron and MSD, and a recipient of unrestricted research grants from Johnson & Johnson and MSD. S. Sahay is a consultant and advisor for Merck, United Therapeutics, Keros, Morphic, Pulmovant and Gossamer Bio, clinical trial site PI for United Therapeutics, Keros and Pulmovant, and a data and safety monitoring board chair and member for NIH funded studies.

Comment on

  • Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbidities.
    Boucly A, Montani D, Bauer F, Artaud-Macari E, Bergot E, Boissin C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, du Roure C, Favrolt N, Horeau-Langlard D, Jaïs X, Jevnikar M, Lacoste-Palasset T, Picard F, Prévôt G, Reynaud-Gaubert M, Roche A, Turquier S, Humbert M, Sitbon O, Savale L. Boucly A, et al. Eur Respir J. 2025 May 6;65(5):2400895. doi: 10.1183/13993003.00895-2024. Print 2025 May. Eur Respir J. 2025. PMID: 39884763